Journal of Clinical and Experimental Hepatology
Издатель: Elsevier · ISSN 0973-6883 · 61 статей
- Retraction notice to "Is MetALD a Distinct Entity or a Transitional Label? Reassessing the Primacy of Alcohol in Steatotic Liver Disease" [Journal of Clinical and Experimental Hepatology 16 (2026) 103557]
- Acculturation, Social Disparities, and Metabolic Dysfunction-Associated Steatotic Liver Disease in Mexican Americans
- Beyond the Rebound and the Calculator: Dynamic Prognostication After Plasma Exchange in Pediatric Acute Liver Failure
- Extracorporeal Liver Support techniques in Acute Liver Failure: A Need for Practice Standardization A Multicenter Survey in Canadian and French Liver Transplant Centers
- Expanding The Scope of Endohepatology: A Single Center Experience of Endoscopic Ultrasound guided Locoregional Therapies for Hepatocellular Carcinoma [With Video]
- PNPLA3 as a severity modifier and the susceptibility–progression distinction in Indian MASLD: response to Kaushal et al.
- Corrigendum to “Post Hoc Analysis of a Phase 2 Randomized Trial of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease: Associations With Platelet Count, Liver Stiffness, and Spleen Volume” [J Clin Exp Hepatol 16 (4) (2026) 103525]
- Pancreatic Exocrine Insufficiency in Indian MASLD: Prevalence and Predictors Versus Health-Check Controls
- Artificial Intelligence in Liver Transplantation: The Next Frontier in Clinical Decision-Making
- Incidence, Predictors, and Course of Hepatocellular Carcinoma Following Direct-Acting Antivirals Therapy in a Prospective Genotype-3 Predominant HCV Elimination Compensated Cirrhosis Cohort
- Digital Stool Colour Card for Biliary Atresia Screening in North India: A Prospective Feasibility and Reliability Study
- Validation of AGILE 3+ and AGILE 4 Scores for Assessing Advanced Fibrosis and Cirrhosis in Indian Patients With Nonalcoholic Fatty Liver Disease: An Indian Consortium on Non-alcoholic Fatty Liver Disease Study
- Efficacy of Structured Lifestyle Intervention in Normal Body Mass Index Non-alcoholic Fatty Liver Disease
- Significant Liver Fibrosis in Pre–Metabolic Dysfunction—Associated Alcohol-Relate Liver Disease Population: A Nationally Representative Analysis of Moderate Drinkers With Cardiometabolic Risk Factors
- Peripheral Neuropathy and Restless Legs Syndrome in Cirrhosis: An Electrophysiological Cross-sectional Study
- Genetic Susceptibility Versus Fibrosis Progression in North Indian Metabolic Dysfunction–Associated Steatotic Liver Disease: Distinct Roles of APOC3 and PNPLA3 in a Candidate Gene Study
- Etiological Spectrum, Outcomes, and Diagnostic Yield of Computerized Tomography of the Head in Cirrhotic Patients With Altered Mental Status
- Diabetes-associated Alterations in the Gut Microbiota–metabolite Profile of NAFLD Under Complex Clinical Conditions
- Right-Lateralized Side-to-side Cavo-caval Anastomosis With Right Hepatic Vein–Extended Cavotomy in Deceased-donor Liver Transplantation: Technique Standardization and Early Outcomes
- Endoscopic Ultrasound-guided Versus Percutaneous Liver Biopsy in Diagnosing Liver Parenchymal Disease: A Prospective Cohort Study
- Effect of Blood Group on von Willebrand Factor Antigen Levels in Compensated Advanced Chronic Liver Disease and Utility of von Willebrand Factor–Platelet Ratio for Detecting Clinically Significant Portal Hypertension
- Prevalence and Clinical Significance of the Hepatitis C Virus Core Protein 70Q/H Mutation and Its Association With Hepatocellular Carcinoma-Related Markers in Mexican Patients
- Effect of Incentive Spirometer on Arterial Blood Gases in Liver Transplant Recipients
- Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in the Indian Ethnicity: An Update
- Reframing MASLD: A Hepatic Condition With Systemic Clinical Impact
- Scoping Review on Polycystic Liver Disease in PKD1/PKD2 Gene Carriers: Genetic Aspects, Pathophysiology, and Therapeutic Approaches
- Plant-based Dietary Patterns and the Risk of Metabolic Dysfunction–Associated Steatotic Liver Disease and Liver Cancer: A Systematic Review and Meta-analysis
- Methodological Considerations in the Interpretation of Non-invasive Surrogate Markers in a Post Hoc Analysis of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease
- Discrimination is Not Clinical Utility: Calibration and Net Benefit Before a Noninvasive Her2 Framing in Gallbladder Cancer
- The Sirens of Precision Medicine in MASLD: Are We Sailing Beyond the Evidence?